A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine

Archives of Neurology

Volumn 53, Issue 2, 1996, Pages 180-184

  Winner, Paul ^a   Ricalde, Orlando ^b,g   Le Force, Bruce ^c,f   Saper, Joel ^d   Margul, Betty ^e  

^a Palm Beach Headache Center   (United States)

^b KEESLER MEDICAL CENTER   (United States)

^c Lackland Air Force Base ^*  (United States)

^d Michigan Hd Pain Neurologic Inst   (United States)

^e Sandoz Pharma Ltd   (Switzerland)

^f Tulane University Medical School ^*

^g TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROERGOTAMINE MESILATE; METOCLOPRAMIDE; PROCHLORPERAZINE; SUMATRIPTAN SUCCINATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION; THORAX PAIN; VOMITING;

EID: 0030020852     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550020092020     Document Type: Article

References (6)

1. McCarthy BG, Peroutka SJ, Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR 43175). Headache. 1989,29.420-422.
2. Saadah HA Abortive therapy with intramuscular dihydroergotamme. Headache. 1992;32:18-20.
3. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med. 1991;325:316-321.
4. Headache Classification Committee of ths International Headache Society. Classification and diagnostic criteria of headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988,8(suppl 7):1-96.
5. Fleiss J. Statistical Methods for Rates and Proportions. 2nd ed. New York. NY: John Wiley & Sons Inc; 1981:25-26, 173-175.
6. Winner P, Dalessio D, Mathew N, et al. Office-based treatment of acute migraine with dihydroergotamine mesylate. Headache. 1993;33:471-475.